In this week's podcast episode, we will review recent literature on ineffectiveness of laxatives and learn about indications for newer agents.

Can peanut allergy be prevented in children? This podcast episode will review the newest AAP recommendations on feeding in the first year of life, with a special emphasis on preventing atopic disorders. Our objectives will be to review feeding recommendations, discuss methods to decrease risk of atopic disorders in high risk children and consider future research in pediatric feeding recommendations.

Kids love fruit juice. But how much is OK? What are the facts on fruit juice consumption in kids and what should you advise the families you care for? In this episode, we will discuss the latest recommendations from the American Academy of Pediatrics and how they may impact your practice.

In this podcast episode, we will discuss current guidelines for a concussion evaluation or work-up as well as return to activity following a concussion. We will also put a paper on this topic into context and consider what impact this should have on your practice.

This episode will build on the previous podcast with a focus on how to apply the management guidelines in Asthma with a focus on critical features to know for board preparation. Our objectives will be to understand how to clinically apply the guidelines and consider consider environmental factors in asthma management.

In this podcast episode, we will talk about how systolic hypertension affects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8. We will also discuss the Number Needed to Treat (NNT) and the Number Needed to Harm (NNH).

HPV immunization has been recommended for pre-teens and teens for over a decade, however vaccination rates remain low. In October 2016 the CDC changed their recommendations to 2 doses of HPV vaccine in teens before their 15th birthday (from 3 doses), does this make it easier for completion?

In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.

Corticosteroids are often prescribed for short-term use for conditions such as asthma exacerbation, contact dermatitis, gout, and Bell’s palsy. Adverse effects from chronic use of corticosteroids is well known, but many clinicians believe that the risk of significant adverse effects from short-term use is minimal. A recent retrospective cohort study was done reviewing the records of 1.5 million adults to assess the adverse effects of treatment with corticosteroids for less than 30 days.

Is Alternate day fasting the future of weight loss? Maybe not….

In this podcast episode, we will consider the rationale for using non-fasting labs to screen for ASCVD as well as review the controversies around their use and talk about the differential diagnosis of hypertriglyceridemia.

Lipoprotein(a) is a genetically determined LDL-C like particle that is uniquely proatherogenic, prothrombotic, and proinflammatory. While emerging therapies are on the horizon, there are no current FDA approved medicinal treatment options for Lp(a). Understanding the prevalence and need to test for Lp(a) will help your patients mitigate potential cardiovascular risks via lifestyle modification and informing clinical practice. This interactive module will cover: • The differences between LDL-C and Lp(a) • Testing and incidence of Lp(a), as well as associated diseases • Cardiovascular risk and risk-enhancing factors that can lead to cardiovascular events • Lifestyle management and risk factor mitigation